Cetuximab as salvage therapy in 82 year old women with metastatic colon cancer

被引：0
|
作者：
Krzemieniecki, Krzysztof [1 ]
机构：
[1] Uniwersytetu Med Krakowie, Coll Med, Klin Onkol, Ul Sniadeckich 10, PL-31531 Krakow, Poland
来源：
ONCOLOGY IN CLINICAL PRACTICE | 2012年 / 8卷 / 02期
关键词：
metastatic colon cancer; elderly patients; cetuximab;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Anticancer treatment offered to elderly requests basic knowledge on geriatric problems and understanding the limits related to reduced functional reserves. Cetuximab was prescribed as the rescue monotherapy to 82 years old women with metastatic colon cancer following failure of systemic treatment. The decrease in bothersome disease symptoms and temporary remission of metastatic lesions revealed in the imaging assessment were observed during treatment. Patient survived additional 10 months. Treatment was well tolerated and toxicity was easy manageable. Monotherapy with cetuximab can be a valuable palliative option in the adequately selected patients.
引用
收藏
页码：65 / 66
页数：2
相关论文
共 50 条
  • [31] Excellent Biochemical Response to Polychemotherapy with Nab-Paclitaxel/Gemcitabine in an 82-Year-Old Female with Metastatic Breast Cancer
    Voelkl, Siegfried J.
    CASE REPORTS IN ONCOLOGY, 2014, 7 (03): : 638 - 642
  • [32] Maintenance Therapy With Cetuximab After FOLFIRI Plus Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer
    Boige, Valerie
    Blons, Helene
    Francois, Eric
    Ben Abdelghani, Meher
    Phelip, Jean-Marc
    Le Brun-Ly, Valerie
    Mineur, Laurent
    Galais, Marie Pierre
    Villing, Anne-Laure
    Hautefeuille, Vincent
    Miglianico, Laurent
    De La Fouchardiere, Christelle
    Genet, Dominique
    Levasseur, Nadia
    Levache, Charles-Briac
    Penel, Nicolas
    Mitry, Emmanuel
    Jacquot, Stephane
    Aparicio, Thomas
    Brument, Emilie
    Gourgou, Sophie
    Castan, Florence
    Bouche, Olivier
    JAMA NETWORK OPEN, 2023, 6 (09) : e2333533
  • [33] Cetuximab-based therapy in elderly comorbid patients with metastatic colorectal cancer
    Jehn, C. F.
    Boening, L.
    Kroening, H.
    Possinger, K.
    Lueftner, D.
    BRITISH JOURNAL OF CANCER, 2012, 106 (02) : 274 - 278
  • [34] Cetuximab-based therapy in elderly comorbid patients with metastatic colorectal cancer
    C F Jehn
    L Böning
    H Kröning
    K Possinger
    D Lüftner
    British Journal of Cancer, 2012, 106 : 274 - 278
  • [35] Cetuximab plus FOLFOX 6 as first line therapy for metastatic colorectal cancer
    Scott, J
    Dakhil, S
    Cosgriff, T
    Pink, C
    Butler, B
    Boccia, RV
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 297S - 297S
  • [36] COLON-CANCER IN A 16-YEAR-OLD GIRL
    ECCLES, DM
    BUNYAN, DJ
    NEEDELL, J
    THOMPSON, M
    LANCET, 1995, 345 (8965): : 1643 - 1643
  • [37] Update on novel strategies to optimize cetuximab therapy in patients with metastatic colorectal cancer
    Macarulla, Teresa
    Javier Ramos, Francisco
    Elez, Elena
    Capdevila, Jaume
    Peralta, Sergio
    Tabernero, Josep
    CLINICAL COLORECTAL CANCER, 2008, 7 (05) : 300 - 308
  • [38] Colon cancer in a 12-year-old girl with hypertriglyceridemia
    Pedroni, Monica
    de Leon, Maurizio Ponz
    Bonetti, Luca Reggiani
    Viel, Alessandra
    Noto, Davide
    Nascimbeni, Fabio
    Sena, Paola
    Roncucci, Luca
    METABOLISM AND TARGET ORGAN DAMAGE, 2022, 2 (01):
  • [39] Correction to: Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer
    A. Matrone
    A. Prete
    A. Nervo
    A. Ragni
    L. Agate
    E. Molinaro
    C. Giani
    L. Valerio
    E. Minaldi
    A. Piovesan
    R. Elisei
    Journal of Endocrinological Investigation, 2021, 44 : 2859 - 2859
  • [40] Raltitrexed as salvage therapy for metastatic colorectal cancer: A multicenter retrospective study
    Ghanem, I.
    Viudez, A.
    Garcia-Torralba, E.
    Torres-Tenor, J.
    Carmona, A.
    Vera, R.
    Rodriguez-Salas, N.
    de la Pena, F. Ayala
    Higuera, O.
    Feliu, J.
    ANNALS OF ONCOLOGY, 2018, 29
12345